Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research

Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk.  Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards.  Read this case study for lessons learned.

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research published by Takka Technologies

The digital revolution is transforming our organizations and industries, offering new opportunities and challenges. In this context, Takka Technologies' mission is to bring its customers to their full operational potential by making the most of this digital ecosystem. Takka offers intelligent workflow automation solutions so that allow SMEs (and other organizations) can to stay focused on their value chain. Through industry-specific data management, Takka provides its customers with tools to make data-driven decision-making (DDDM).

Takka Technologies fournit des solutions logicielles d'automatisation de processus métier aux PME qui recherchent davantage de performances, de fiabilité et de données structurées dans leur chaîne de valeur ou des activités de support. Les solutions fournies par Takka Technologies incluent la création d'outils et indicateurs qui aident l'entreprise à passer d'un mode de prise de décision traditionnelle à un mode de prise de décision basée sur les données (DDDM).

Home
Contact Us
Fair Use
The material on this site is provided for educational and informational purposes. All photos that haven't been taken by us have either been purchased, used with permission, credited and linked back to their original sources or believed to be public domain. It is believed that this constitutes a `fair use` of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have an interest in using the included information for research and educational purposes. If you wish to use copyrighted material from this site for purposes of your own that go beyond `fair use`, you must obtain permission from the copyright owner.

The full experience is only one step away!

Takka Technologies is ready to help!

Please confirm your email address!

Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research